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Although  a  large amount of  work  in  several  countries  has  been 
done  relative  to  the  production  of  an  effective antimeningococcic 
serum,  the problems involved  have not  yet  been wholly resolved. 
The increased demands arising from war conditions acted as a  potent 
stimulus first to simplify manufacture and then to insure an effective 
product.  This paper  records  primarily  attempts  to  simplify  the 
manufacture of an efficacious serum and deals incidentally  with a num- 
ber of still mooted, questions regarding the antigenic properties of the 
meningococcus on  which  the  production  of  such  a  serum  largely 
rests. 
It  is  now generally recognized  that  the  meningococcus is  not  a 
simple, fixed antigenic entity but rather that the term meningococcus 
covers a  class  of closely related microorganisms,  the  distinguishing 
common characters of which relate to certain cultural and fermenta- 
tive  qualities  and  the power to  set  up  in man  particular  forms of 
inflammation  of  the  leptomeninges,  while  they  differ markedly in 
their  immunologic  responses.  Thus  for  identification  the  cultural 
properties are of first importance and for serum production the anti- 
genic structure is paramount. 
Ever since Dopter  1 first distinguished the immunologically distinct 
parameningococcus the  classification of  the  meningococci has  been 
under discussion and agreement has not yet been reached.  Everyone 
admits the existence of two main groups called normal or regular me- 
ningococcus  and  parameningococcus;  the  disturbing  factor  is  the 
1Dopter,  C.,  Compt. rend. Soc. biol., 1909, Ixvii, 74.  Dopter  and Pauron, 
Compt. rend. Soc. biol., 1914, lxxvii, 231. 
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occurrence of intermediate cocci which resemble either the  regular 
meningococcus or  the  parameningococcus but  are  immunologlcally 
less sharply defined than are the pure types of the main groups.  This 
fact has led to  the setting up  of main and subsidiary types as', for 
example,  in  Gordon's  classification which  recognizes four  types  of 
meningococci.  ~  But  Gordon's  classification  has  not  received  gen- 
eral acceptation and for the reason that observers cannot agree on 
the two subsidiary type strains. 
These considerations have far more than theoretical interest, since 
experience has  shown  that  a  therapeutically effective antimeningo- 
coccic serum should possess wide capacities of immunologic activity 
as measured by the agglutinin content.  Since the early work on the 
subject by Flexner and Jobling  3 and the later studies of Amoss  and 
Wollstein,* it has beenthe custom to employ for the immunization of 
horses  a  large number  of  cultures including  representatives of  the 
regular,  the para,  and  many intermediate strains  of  the menlngo- 
coccus.  The number of strains used in the antigen might reach 50 
or more, depending upon  the reaction of the serum with meningo- 
cocci derived from the cerebrospinal fluid of many cases of epidemic 
meningitis.  When the test with such  a  culture showed  low agglu- 
tination titer the strain was added to those used for immunization. 
The purpose of this was to produce a serum with as wide an aggluti- 
nation index as practicable. 
It is obvious that this procedure implies an empirical method.  In 
endeavoring to simplify the manufacture of antimeningococcic serum 
it seemed worth while to determine more precisely than had yet been 
done whether a wide agglutination index could be obtained from a small 
number of antigenically different strains.  Several facts had already 
rendered it probable that something in this direction was achievable. 
For example, it  had been noted  thai the immunity response in the 
horse was wider than in the rabbit and also that the longer the injec- 
tions of certain fixed cultures were continued, the more inclusive the 
agglutinin content became.  In addition to these essential data there 
Gordon, M.  H., Med.  Research Com., Nat. Health Insurance,  Special Rep. 
Series, No. 3, 1917, 10. 
8 Flexner, S., and Jobling, J. W., J. Exp. Mecl., 1908, x, 141. 
4  Amoss, H. L., and Wollstein, M., J. Exp. ivied., 1916, xxiii, 403. B:.  L.  AMOSS,  F.  L.  GATES,  AND  P.  K.  OLITSKY  769 
was a still further important fact; namely, that approximately 80 per 
cent of all cases of epidemic meningitis arose from infection with the 
two  type strains;  that is,  the  regular meningococcus and  the para- 
menlngococcus.  Hence the production of an effective serum for this 
large  proportion  of  cases  of  meningitis  appeared  to  be  relatively 
simple; the real problem was to make the serum effective against the 
20 per cent of cases due to the highly variable subsidiary strains. 
Fortunately, we possessed as a standard of comparison for the sera 
to be produced with a limited number of strains,  samples of poly- 
valent  sera,  of  established  therapeutic  efficacy,  which  had  been 
produced at The Rockefeller Institute by the injection of 51  spinal 
cultures of the menlngococcus selected in accordance with the method 
outlined  above.  5  These  51  cultures  were  classified  as  follows:  10 
were regular,  26  were para,  and  15  were  intermediate (subsidiary) 
strains of menlngococcus,  s 
Horse Sera Produced  with a  Small  Number  of Strains. 
When the experiments with horses with a smaller number of cultures 
of the menlngococcus were begun in  1917 we had already observed 
flaat rabbits which were immunized with a  single type strain  over 
long periods  of  time yielded sera  which  cont~ed  agglutinlns not 
only for that strain but also, in less amount, for heterologous strains 
including even those of the opposite type. 
Use of Five Strains as Antigen.--The  experiments described below 
were made on two horses  (N0s.  M  24  and  M  25).  Injections were 
begun  with  four  cultures  which  were  classed  immlmologicaily as 
s The polyvalent serum issued for therapeutic  purposes was  composed of 
serum from at least three horses.  Because of the variation in the response of 
different horses, it has been our practice to pool serum from several horses to 
insure a properly balanced product. 
s In 1914 two strains of parameningococcus were brought from Dopter by a 
member of the staff of The Rockefeller  Institute.  It was on the basis of these 
strains that our classification  was made.  Recent comparison  of our stock strains 
with sera and cultures lately obtained from England and France shows that our 
original classification  is the reverse of the present accepted grouping.  Conform- 
ing to general usage, we have revised our classification  in this paper, so that the 
regular or normal group mentioned in previous papers from these laboratories is 
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follows: Culture  1,  para type strain;  Culture 60,  regular type strain; 
and  Cultures  30  and  31  of  different  intermediate  types.  Serum 
obtained in  early bleedings  of these horses  did  not  agglutinate  Cul- 
ture  38  (also an intermediate)  which was then  added  to the antigen. 
Experiment/.--The  method of immunization was as follows: After a glanders 
test and the subcutaneous injection of 1,500 units of antitetanic  serum,  Horses 
M  24 and M 25 were tested for sensitiveness to the meningococcus  by the intra- 
venous injection of minute doses  (0.05 cc.) of a saline  suspension (2.5 cc. to  an 
agar slant culture).  The immunizing injections wore begun on  November 29, 
1917, living cultures being given in a  total dose of 0.12 cc.,  and were continued 
according to  the method described by Amoss and Wollstein)  Trial bleedings 
were made with Horse M 24 after 3, 10, and  14 months,  and with Horse M  25 
after 2,  10, and 14 months. 
TABLE  I. 
Number  of  Stock  Strains  Agglutinated  by  the  Serum  of  Horses  M  24  and  M  25 
Immunized  with  Five  Strains  of Meningococcus. 
Horse No. 
M 24 
"  24 
"  24 
"  25 
"  25 
"  25 
Duration of immunization. 
m0$. 
3 
10 
14 
2 
10 
14 
Agglutination test positive. 
1:400 or higher. 
35 of 51 
43 "  60 
51  "  56 
35 "  58 
32  "  60 
47 "  56 
1:100 
50 of 51 
59 "  60 
56 "  56 
40 "  58 
58  "  60 
56 "  56 
In Table I  the progress of the immunization is summarized accord- 
ing to the number of stock strains  (cultures)  which were agglutinated 
in  a  serum  dilution  of  1 : 100  and  of  1 : 400  or higher.  51  of  these 
stock strairts were  those  used in  the  manufacture  of  the  therapeutic 
polyvalent serum. 
Table I  indicates  that by employing for purposes of immunization 
as few as five cultures,  representing different strains,  of the meningo- 
coccus,  a  serum is produced  which  shows  considerable  agglutinative 
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English type strains. 7  The titer of the serum for this large number 
of cultures equalled that previously required for a polyvalent serum 
prepared with a far larger number of cultures. 
Use of Three Strains as Antigen.--In  this  experiment the  strains 
were reduced to three, representing regular and para types. 
Experiment  2.--The procedure with Horse M  31  was similar to that already 
described.  The injections were begun on May 1,  1918, and trial bleedings were 
made after 5  and 9  months of immunization.  Two  regular  cultures  (Strains 
60 and 79)  and one para culture (Strain 85)  were employed for the injection. 
Table II summarizes the results obtained, which are the equivalent, 
for  the  same ~  period  of injection,  of  those  obtained with  the  five 
strains  as  shown by Table  I.  Although thirteen of the stock cul- 
tures did not agglutinate in  the  1:400  dilution after 9  months of 
immunization all were agglutinated in dilutions ranging from  1:50 
to 1:200. 
TABLE  IX. 
Number  of Stock  Strains  Agglutinated  by the Serum of Horse M  31 Immunlzed 
witk Tkree Strains of Meningococcus. 
Duration of immunization. 
mo$, 
5 
9 
Agglutination  test positive. 
1:400 or higher. 
32 of 50 
43 "  56 
1:I00 
47 of 50 
55 "  56 
Monovalent Horse Sera. 
The total amount of meningococcic antigen which can be given a 
horse varies and is obviously limited.  The use, therefore, of a  single 
antigen might result in a greater antibody content for the homologous 
strain  than  could be  obtained  against  the  individual strains  of  a 
multiple antigen.  Indeed, certain therapeutic monovalent sera have 
been prepared in  this way by  the Pasteur  Institute  and more re- 
cently by Gordon and others in England working under the Medical 
7 The English type strains were kindly supplied by Dr. Gordon. 772  PRODUCTIOI~  O]~ ANTIM~IqII~GOCOCCIC  SERUM 
Research Council.  8  The intent in both these instances was to fortify 
the  therapeutic activity of the serum for treating cases of epidemic 
meningitis with  type antisera  after  the  type of infecting meningo- 
coccus had been determined. 
It is not our intention in this place to discuss the practicability of 
this  method of  procedure  or  even  to  analyze  the  results  thus  far 
secured by the English investigators mentioned above.  We would 
remark, however, that we are dubious as to the advisability of mak- 
ing a  substitution of a  monoserum for an active polyserum in view 
of the uncertainties and "lack of uniformity which still surround the 
practical work of determining and distinguishing the so called types 
of meningococci.  But as the data which follow show; the antigenic 
constitution of even type meningococci is such that a strictly monova- 
lent serum is not produced when horses are injected with a type cul- 
ture over a long period of time. 
The  experiments  on  monovalent sera  were  made  in  two  ways: 
first,  by injecting as  many as  three  cultures of  the  same  type  of 
meningococcus, and second, by injecting a  single type culture only. 
Experiment 3.--Horse M 30, after the usual preliminary treatment,  was first 
injected with suspensions of living parameningococci (Cultures 1, 4,  and  36). 
After 6 and 10 months of immunization trial bleedings were made.  The serum 
thus obtained was titrated against 56 stock cultures of meningococci with the 
results shown in Table III. 
TABLE  III. 
Number of Stock Strains  Agglutinated by the Serum  of Horse M  30 Immunized 
~th Three Strains of Parameningococcu.~. 
Duration of immunization. 
f/los, 
6 
10 
Agglutination test po61tlve. 
1:400 or higher. 
40 of 52 
56 " 56 
1:100 
50 of 52 
56 " 56 
The results were striking and unexpected, and yet they confirmed 
certain  tests  which  we  had  previously made  on  the  variations  in 
s Hine, T. G. M., Pr~y Council, Med. Research Council, Special  Rep.  Series. 
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agglutinogenlc activity exhibited by different strains of the menlngo- 
coccus.  It appears that in this respect separate  strains  of  the  me- 
ningococcus show a wide variation.  It has been noted also that horses 
vary in  their  response (cf. Nos.  M  24 and  1Vi 25, Table I). 
The  next  step  was to  determine  the  effect of immunizing  horses 
with single type strains  of the regular meningococcus and  the para- 
meningococcus.  For this purpose two horses were employed. 
Experiment 4.--Horse M 32 was injected with a para culture (No. 1) and Horse 
M  33 with  a regular culture  (No. 60).  The immunization was begun on De- 
cember 5, 1918, and test bleedings were made 3 months later at a period still too 
early to show the final wide range of agglutinative capacities of the sera.  How- 
ever, the serum of Horse M 32 (para) agglutinated in dilutions of 1: 400 or higher 
52 of the 56 stock cultures, and the serum of Horse M 33  (regular) agglutinated 
in the 1:400 dilution or higher 51 of the 56 stock cultures. 
These results raise  certain  very pertinent  questions which  cannot 
be answered  offhand.  We have dealt with certain  aspects of  these 
questions in a later section of this paper in connection with the changes 
which take place in the sera during storage and  the response of the 
sera  produced  in  different  ways  to  selective absorption tests.  We 
possess many observations which  point  to  the  greater  efficacy of  a 
truly polyvalent antirneuingococclc serum in practice,  and hence we 
do not accept,  as yet, such an apparently polyvalent serum,  arising 
from single type cultures,  as being immunologically and  therapeuti- 
cally equivalent  to  the former.  The results given show also that an 
immune  horse  serum  cannot  be used  for  classifying  meningococci, 
and  finally,  that the  so called monovalent  sera prepared  in  France 
and England in the horse doubtless possessed agglutinative capacities 
far wider than is implied in their names. 
Comparative A gglutinin Content of Monovalent and Polyvalent Sera. 
The  experiments on horses with single and with several strains  of 
meningococci have shown  that  agglutiuin  formation  is  induced  not 
only for the strain or strains injected but also for a wide number and 
diversity of other type and subsidiary strains.  At first sight  it  may 
appear that  the sera produced with single and with multiple strains 
are practically  identical  and  could be substituted  for  each  other in 774  PRODUCTIOI~  OF  AI~TI~EIqI~GOCOCCIC SERUM 
treatment.  And yet  this  deduction would  not be justified,  as  the 
following tests show.  It is also in conflict with observations on the 
efficacy  of  widely  polyvalent  antimeningococcic  serum  known  to 
contain specific agglutinins for the main and subsidiary strains of the 
meningococcus. 
Effects of Storage.--The  first tests to be described here relate to the 
comparative keeping qualities of  the two kinds of sera.  The samples 
of mono- and  polyvalent horse  sera  were kept  in  the refrigerator 
in the dark at an approximate temperature of 4°C. for about 1 year. 
All the sera had been preserved with 0.15  per cent  tricresol.  The 
sera tested were derived from Horses M  32  (monovalent para), M  33 
(monovalent regular), M  24 (regular, para, and three intermediates), 
and M 31 (three regular).  The polyvaient serum used for comparison 
was  obtained  by pooling  the serum  of six horses, each immunized 
over a long period of time with 50 odd strains. 
The tests of keeping qualities took into account only the aggluti- 
nins, which can be quantitatively .determined.  The titrations were 
made  with  suspensions  of  killed  cultures  which  were  uniform  for 
all the tests. 
The results of the tests are shown graphically in Text-fig. 1.  While 
the polyvalent serum has fallen off but little during a  year's storage 
and still agglutinates all of the 41 strains of meningococci employed, 
the  two monovaient sera have lost  agglutinating power for a  con- 
siderable number of the strains  (sixteen in  the case of Horse M  32 
(para type)  and  ten in Horse M  33  (regular type)).  On the other 
hand,  the three strain  serum  (Horse M  31)  and especially the five 
strain (Horse M  24)  approach in value the polyvalent serum.  The 
serum of Horse M  24,  in a dilution of at least 1: 50, agglutinated 39 
of the 41  strains. 
The  chart  brings  out  the  important  fact  that  the  common  or 
secondary agglutinins are the first to disappear from the serum and 
that specific agglutinins for homologous strains are reasonably stable 
during storage.  This is a  point of capital distinction and may well 
prove to be the determining factor in respect to the manufacture as 
well  as  to  the  therapeutic efficacy of the various  sera.  The  strik- 
ing difference as shown by the pooled polyvalent serum relates to its 
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TExT-FIG. 1.  An agglutination test with five sera after storage for 1 year or 
longer in the ice box.  In four of the sera asterisks indicate homologous strains. 
Complete agglutination in any dilution is represented by a  broad black band 
and indicates the flocculation of all organisms, leaving a  clear supernatant fluid, 
even  after  shaking.  Incomplete  agglutination,  represented  by  a  band  of 
medium width, indicates the flocculation of almost all the organisms, the super- 
natant  fluid remaining hazy after  shaking.  Partial agglutination,  represented 
by a  narrow band, indicates the presence of distinct flocculi which d.o not disap- 
pear on shaking, although the supernatant  fluid is cloudy with unagglutinated 
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is obvious that as the monovalent sera lose their secondary (or com- 
mon) agglutinins they become more suitable for use in type diagnosis, 
and  pari  passu,  more  unsuitable  for  therapeutic  purposes.  One 
further  matter  may  be  pointed  out.  The  standard  polyvalent 
serum was  prepared  by pooling  the  sera  derived  from  six  horses. 
The sera prepared with three and five strains respectively came each 
from one horse.  Reasoning by analogy and taking into account the 
response of different horses to injections  of  various  strains  of  me- 
ningococcus, for example, Horses M  24 and M  25, it is quite possible 
that the pooling of sera prepared from a small number of type strains 
might yield an enduring and still more inclusive serum. 
Effects  on Absorption of Agglutinir~.--The  differences in deteriora- 
tion on storage point to a  fundamental difference in the monovalent 
as compared with the polyvalent sera which is confirmed by the test 
for absorption  of agglutinin as is  shown graphically in Text-fig.  2. 
In Columns 1 and 2 are shown the control agglutination tests made 
with a  14 month sample of the pooled polyvalent serum and a  fresh 
sample of monovalent para serum  (Horse NI  32)  before absorption 
with killed cultures of Strains 1  (the homologous para strain)  and 5 
(also  of  para  type).  Mter  triple  absorption  under  carefully  con- 
trolled conditions, it was found that the single strains had removed 
all the agglutinins with which they could react, since further absorp- 
tion  did  not  reduce  significantly the  agglutinins  remaining in  the 
. serum. 
Text-fig. 2 shows that Strain 1,  the homologous strain,  exhausted 
the monovalent serum completely, but  was unable to  exhaust the 
polyvalent serum, leaving agglutlnlns with which 30  of the 44  test 
strains were able to react.  Similarly, while Strain 5,  another strain 
of  the  same  type,  removed  from  the  monovalent  serum  all  the 
agglutinins with which 27 of the 44 test strains had reacted in the con- 
trol tests, a  similar treatment of the polyvalent serum left available 
agglutinins  for  all  but  9  of  the  44  test  strains.  This  experiment 
emphasizes the differenge in the inherent character of the polyvalent 
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TZXT-FIo.  2.  A  comparison  by  agglutination  of  standard  polyvalent  serum 
and of para monovalent serum before and after absorption  three times with a 
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Employment of Killed Cultures. 
The  preparation  of  therapeutic  meningococcic serum with living 
antigen is laborious and difficult.  Because of the rapidity with which 
the  meningococcus dies  in  artificial cultures,  frequent  transfers  on 
serum  media, must  be  made,  and  the  cultures  to  be  used  for  the 
immunizing injections must be freshly prepared each time in a plain 
agar medium.  The question arises, therefore, whether the practical 
operations  cannot be  simplified by  the  employment, at  least  over 
certain periods, of killed cultures of the meningococcus so prepared 
as  to  prevent  the  autolysis which  tends  to  destroy  the  antigenic 
properties.  We have not carried out an exhaustive study of this sub- 
ject but from many tests on rabbits and the following experiment with 
Horse M  28, we are of the opinion that the subject is worthy of thor- 
ough investigation. 
Experiment  5.--Because of the rapidity with which the meningococeus  auto- 
lyzes in cultures, growths in plain agar in Blake bottles, incubated at 37°C. for 
8 to 10 hours, were employed.  The surface growths were washed off with 20 ce. 
of isotonic "saline solution and the heavy suspensions were quickly heated in a 
water bath to 65°C. to destroy the autolyfic ferment.  Test for viability was made 
and 0.35 per cent tricresol added.  The suspension was kept in the refrigerator. 
Horse M 28, after the usual preliminary treatment,  was injdcted, beginning 
January 4,  1918, with suspensions of killed cultures of the same strains  that 
were used in the immunization of Horses M 24 and M 25; viz., No.  1 (para), 
No. 60 (regular), and Nos. 30, 31, and 38 (intermediates).  The test serum bleed- 
ings were made after 7 and 12 months of immunization with the results shown in 
Table IV. 
TABLE  IV. 
Number  of Stock Strains  Agglutinated by the Serum  of Horse M  28 Immunized 
with Killed  Cultures of Five Strains. 
Duration of immunization. 
mas. 
7 
12 
Agglutination test positive. 
1:400 or higher. 
• 46  of 60 
53  "  56 
1:100 
59 of 60 
56  "  56 
This single experiment may be taken merely to indicate that as far 
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ningococci can be used for immunizing horses.  It will be patent from 
all  the  circumstances and  from what  has  been  stated  above,  that 
this fact is not regarded as tantamount to the conclusion that a thera- 
peutically active and efficacious antimeningococcic serum can be pro- 
duced in this way.  We should, indeed, be willing to go no further at 
thepresent time than to propose that the suspended killed cultures 
be kept on hand to be used on occasion in place of the suspended live 
cultures  when  for  any  reason  circumstances make it impossible to 
inject  the  latter.  During  the  war  when  antirneningococcic serum 
was being produced at The Rockefeller Institute under great pressure, 
we never relied on the killed cultures alone and, at most, only occa- 
sionally alternated the injection of the killed and the living cultures 
in  the  routine manufacture of  antimeningococcic serum.  We  still 
believe in the practice of employing live cultures and also of cultures 
freshly isolated from cases of epidemic meningitis. 
The power of stored killed  cultures,  preserved with  tricresol,  to 
induce agglutinin  formation was  tested  in  one instance in  rabbits. 
The killed cultures had been in the refrigerator for periods of 8  and 
14  months.  The  rabbits  tolerated  the  usual  doses.  One  rabbit 
injected with a killed regular strain gave a serum of 1 : 1,600 titer, and 
another injected with a killed para strain gave a titer of 1 : 800 against 
freshly prepared killed cultures.  The stored killed suspensions were 
agglutinated in  other immune rabbit  sera in high  dilutions.  As  a 
conservative routine, however, the killed cultures employed occasion- 
ally for injection and for agglutinati9n were not used after 3 months 
storage. 
SVM~rAgy A~CD co~cLtrsm~s. 
In an attempt to simplify the manufacture of an efficacious anti- 
meningococcus serum  an  experimental  study has  been  made  of  a 
number of sera produced with a  few or with single strains of menin- 
gococcus, the therapeutic polyvalent serum produced at The Rocke- 
feller Institute with more than 50 strains being used as a standard of 
comparison. 
It was found that horses injected with an antigen limited to five, 
three, or even one  strain  yielded sera with  a  range  of  agglutinins 
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ducing the polyvalent serum.  These sera appeared to equal the poly- 
valent serum in range and titer of agglufinins,  but on further exami- 
nation fundamental  differences were found.  Storage for a  year had 
little effect upon the titer and inclusiveness of the polyvalent serum, 
whereas  the  monovalent  serum  had  fallen  off greatly,  especially in 
regard  to  secondary or  subsidiary  agglufinins,  so that  only a  com- 
paratively  small  number  of  stock  strains  was  still  agglutinated. 
The serum made with five strains,  a  regular,  a para,  and three inter- 
mediate meningococci,  approached  the polyvalent serum  in keeping 
qualities  and  still  agglutinated  at the end of this period 39 of the 41 
strains tested. 
Absorption  tests  also  brought  out  inherent  differences  in  the 
nature  of  the  polyvalent and  the  monovalent  sera  which  had  ap- 
peared to be practically identical in simple agglutination  tests.  The 
homologous strain on triple absorption was able to exhaust the mono- 
valent serum  completely, but was unable  to remove from the poly- 
valent serum agglufinlns to which 30 of 44 different strains were able 
to  react.  Absorption  with  another  single  strain  of  the  same  type 
removed from the monovalent serum agglutinins for a majority of the 
test strains but left the polyvaient serum relatively unaffected. 
It  is  comparatively  easy  to  produce  a  serum  effective  against 
about 80 per cent of the spinal strains of meningococci encountered. 
Deficiencies in our knowledge of the antigenic  capacities  of  the  me- 
ningococcus have led to the more or less empirical use of a large number 
of cultures in the preparation of a serum effective against the remain- 
ing 20 per cent of the strains.  How far the number of the latter in the 
antigen may be reduced without  restricting the efficacy of the  serum 
remains yet to be determined.  However, the experimental  evidence 
recorded here  apparently  does not  favor the use of an  antigen  lim- 
ited  to one or too few strains.  For  example,  three or five selected 
strains  produced  a  serum  which  agglutinated  practically  all  the 
strains against which it was tested.  But in view of the many obser- 
vations  which  point  to  the  greater  therapeutic  efficacy of  a  serum 
made with a  larger number of strains we would not as yet advocate a 
serum  prepared  with  too limited  antigens  even  though  it  contains 
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It  has  been brought  out  that  a  monovalent  serum  contains,  in 
addition ,to specific agglutinins; a wide range of common or secondary 
agglutinins which tend to disappear during storage.  The difference 
between specific and secondary agglutinins is not apparent in simple 
agglutination tests, but is revealed by absorption tests.  It is probable 
that in a serum prepared with a few strains the same condition exists, 
whereas  in  a  serum  produced  with  a  large  number  of  strains  the 
agglutinins are mainly specific as contrasted with the fact that most 
of them are secondary in the serum produced with few strains.  The 
question whether secondary agglutinins are therapeutically equivalent 
to primary or specific agglutiuins requires further study. 
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